With persufflation, helium is used to replace blood in a donated organ. This allows the organ to cool at a rapid rate, requiring less antifreeze. Since pockets of tissue are separated by helium, the risk of fracturing is greatly reduced. If the new technique proves a success, on-demand donor organs may be available for recipients in the future.
Arigos Biomedical developed new technology that can both eliminate fracturing and reduce the effective toxicity of vitrifiable cryoprotectants. I’m glad Breakout Labs funded this research.
This work, along with research from ABI on ice-tempering magnetic fields and a few specific bits of 21st Century Medicine’s ongoing research, seem like the most exciting drop-in technologies coming down the pipeline that could positively improve cryonic suspension protocols used by Alcor and CI in the next 5 years.
See on www.sens.org
